leucine has been researched along with Left Ventricular Hypertrophy in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, XW; Wang, LF; Wang, NF; Xu, HY; Xu, J | 1 |
| Allen, DA; Chesser, AM; Harwood, SM; New, DI; Raftery, MJ; Yaqoob, MM | 1 |
| Asanuma, H; Beppu, S; Hori, M; Ishikura, F; Kitakaze, M; Liao, Y; Minamino, T; Node, K; Ogita, H; Sanada, S; Takashima, S | 1 |
| Andriantsitohaina, R; Babál, P; Bernátová, I; Kyselá, S; Martínez, MC; Pechánová, O; Stvrtina, S | 1 |
| Carabello, BA; Cooper, G; Imamura, T; Kent, RL; McDermott, PJ; Nagatsu, M | 1 |
| Borer, JS; DeMonteiro, C; Magid, NM; Wallerson, DC; Young, MS | 1 |
| Bernátová, I; Pechánová, O; Pelouch, V; Simko, F | 1 |
7 other study(ies) available for leucine and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Association between transforming growth factor beta1 polymorphisms and left ventricle hypertrophy in essential hypertensive subjects.
Topics: Arginine; Asian People; Codon; Genotype; Humans; Hypertension; Hypertrophy, Left Ventricular; Leucine; Mutation; Polymorphism, Genetic; Proline; Transforming Growth Factor beta1 | 2010 |
Calpain is activated in experimental uremia: is calpain a mediator of uremia-induced myocardial injury?
Topics: Acrylates; Animals; Calcium-Binding Proteins; Calpain; Caspase 3; Caspase Inhibitors; Caspases; Cysteine Proteinase Inhibitors; Disease Models, Animal; Humans; Hypertrophy, Left Ventricular; Leucine; Male; Nephrectomy; Oligopeptides; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Uremia | 2003 |
Raloxifene prevents cardiac hypertrophy and dysfunction in pressure-overloaded mice.
Topics: Animals; Constriction; Echocardiography; Hemodynamics; Hypertrophy, Left Ventricular; Leucine; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Myocardium; Myocytes, Cardiac; Pressure; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2004 |
Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension.
Topics: Alkadienes; Animals; Aortic Diseases; Blood Pressure; Blotting, Western; Carbon Radioisotopes; Enzyme Inhibitors; Flavonoids; Hypertension; Hypertrophy, Left Ventricular; Leucine; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; Phenols; Polyphenols; Rats; Rats, Wistar; Vasoconstrictor Agents; Wine | 2004 |
Acute changes in myosin heavy chain synthesis rate in pressure versus volume overload.
Topics: Analysis of Variance; Animals; Blood Pressure; Dogs; Heart Rate; Hypertrophy, Left Ventricular; Kinetics; Leucine; Mitral Valve Insufficiency; Myocardium; Myosins; Radioisotope Dilution Technique; Reference Values; RNA, Transfer, Leu; Stroke Volume; Tritium | 1994 |
Suppression of protein degradation in progressive cardiac hypertrophy of chronic aortic regurgitation.
Topics: Animals; Aortic Valve Insufficiency; Chronic Disease; Echocardiography; Hypertrophy, Left Ventricular; Leucine; Muscle Proteins; Myocardium; Myosins; Rabbits; Time Factors; Tritium | 1993 |
Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Leucine; Male; Muscle Proteins; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; RNA | 1997 |